Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158]
Titel:
Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158]
Auteur:
Kron, Anna Scheffler, Matthias Wiesweg, Marcel Hummel, Horst-Dieter Kulhavy, Jonas Gatteloehner, Stefan Kollmeier, Jens Schubart, Christoph Groß, Thorben Demes, Melanie-Christin Keymel, Stefanie Joosten, Maria Merkelbach-Bruse, Sabine Woelwer, Christina Bianca Tufman, Amanda Kauffmann-Guerrero, Diego Oeser, Katharina Zehaczek, Melanie Jeratsch, Ulli Wolf, Juergen